Dimensional Fund Advisors
AGTC

Dimensional Fund Advisors’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Dimensional Fund Advisors’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-203,000
Closed -$217K – 3558
2022
Q1 		$217K Sell
203,000
-143,927
-41% -$262K ﹤0.01% 3301
2021
Q4 		$659K Sell
346,927
-213,031
-38% -$510K ﹤0.01% 3112
2021
Q3 		$1.69M Sell
559,958
-102,434
-15% -$365K ﹤0.01% 2901
2021
Q2 		$2.59M Sell
662,392
-23,149
-3% -$96K ﹤0.01% 2808
2021
Q1 		$3.47M Sell
685,541
-257,840
-27% -$1.34M ﹤0.01% 2690
2020
Q4 		$3.86M Sell
943,381
-2,797
-0.3% -$13.7K ﹤0.01% 2614
2020
Q3 		$4.6M Sell
946,178
-10,066
-1% -$55K ﹤0.01% 2467
2020
Q2 		$5.3M Sell
956,244
-11,434
-1% -$52.4K ﹤0.01% 2464
2020
Q1 		$3.17M Sell
967,678
-12,045
-1% -$63.5K ﹤0.01% 2565
2019
Q4 		$4.43M Sell
979,723
-55,423
-5% -$175K ﹤0.01% 2651
2019
Q3 		$4.31M Buy
1,035,146
+19,129
+2% +$69.1K ﹤0.01% 2646
2019
Q2 		$3.85M Buy
1,016,017
+47,919
+5% +$196K ﹤0.01% 2724
2019
Q1 		$4.06M Buy
968,098
+56,862
+6% +$199K ﹤0.01% 2712
2018
Q4 		$2.27M Buy
911,236
+93,652
+11% +$549K ﹤0.01% 2830
2018
Q3 		$5.97M Buy
817,584
+85,686
+12% +$375K ﹤0.01% 2625
2018
Q2 		$2.71M Buy
731,898
+99,358
+16% +$460K ﹤0.01% 2815
2018
Q1 		$2.44M Buy
632,540
+124,422
+24% +$523K ﹤0.01% 2827
2017
Q4 		$1.83M Buy
508,118
+113,628
+29% +$429K ﹤0.01% 2871
2017
Q3 		$1.56M Buy
394,490
+128,049
+48% +$588K ﹤0.01% 2910
2017
Q2 		$1.36M Buy
266,441
+106,558
+67% +$599K ﹤0.01% 2922
2017
Q1 		$1.1M Buy
159,883
+114,230
+250% +$892K ﹤0.01% 2960
2016
Q4 		$427K Buy
+45,653
New +$411K ﹤0.01% 3117

Other funds holding AGTC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors's AGTC Position: Q2 2022 in Review

Dimensional Fund Advisors sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2022, closing a stake of 203,000 shares — an estimated $217K sold.

Dimensional Fund Advisors first reported a position in AGTC in Q4 2016 and held it in 22 quarters. The position peaked at $5.97M in Q3 2018. 47 funds tracked by Wall St. Rank hold AGTC as of Q2 2022.

  • Dimensional Fund Advisors reported no remaining Applied Genetic Technologies Corporation position as of Q2 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 203,000 Applied Genetic Technologies Corporation shares in Q2 2022, an estimated $217K.
  • Dimensional Fund Advisors first reported a position in Applied Genetic Technologies Corporation in Q4 2016 and held it in 22 quarters.
  • Dimensional Fund Advisors's Applied Genetic Technologies Corporation position peaked at $5.97M in Q3 2018.
  • 47 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2022.

Based on Dimensional Fund Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.